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 Abstract
Perivascular epithelioid cell tumor (PEC-oma) is a rare mesenchymal neoplasm. Literature reports more than 100 
cases of PEC-oma, a third of which is of uterine or uterine retroperitoneum origin. The case of a 59-year-old woman 
presented here is, to the best of our knowledge, the first described fast uterine PEC-oma recurrence of the tumor 
of the gastrointestinal tract origin. In this text the authors also present literature review concerning this rare female 
tumor.
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 Streszczenie
Perivascular epithelioid cell tumor (PEComa), są bardzo rzadkimi guzami pochodzenia mezenchymalnego. Do 
dnia dzisiejszego odnotowano w piśmiennictwie ponad 100 przypadków PEComa, z czego mniej więcej 1/3 
występowała w macicy lub pokrywającej ją otrzewnej (retroperitoneum). Prezentowany przypadek  59 letniej 
pacjentki jest według nas pierwszym przedstawiającym szybką wznowę zmiany o typie PEComa zlokalizowaną 
w obrębie macicy o pierwotnym punkcie wyjścia z przewodu pokarmowego. W poniższym tekście przedstawiamy 
także przegląd piśmiennictwa dotyczący tego rzadkiego guza kobiecego narządu rodnego.
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Introduction
Perivascular	 epithelioid	 cell	 tumor	 (PEC-oma)	 is	 a	 rare	
mesenchymal	 neoplasm.	 In	 fact,	 histologically,	 the	 term	 PEC-
oma	describes	a	group	of	tumors	and	includes	angiomyolipoma	
(AML),	 clear	 cell	 „sugar”	 tumors	 of	 the	 lung	 (CCST),	
lymphangioleiomyomatosis	 (LAM),	 clear	 cell	myomelanocytic	
tumor	 of	 the	 falciform/ligamentum	 teres	 (CCMT)	 and	
adenocarcinomas	 of	 the	 pancreas,	 rectum,	 peritoneum,	 uterus,	
vagina	 and	 the	 heart	 [1].	 Literature	 reports	 more	 than	 100	
cases	 of	 PEC-oma,	 a	 third	 of	 which	 are	 of	 uterine	 or	 uterine	
retroperitoneum	origin	[2].	The	presented	case,	to	the	best	of	our	
knowledge,	is	the	first	described	fast	uterine	PEC-oma	recurrence	
of	the	tumor	of	the	gastrointestinal	tract	origin.	
Case Report
A	59-year-old	woman	was	admitted	 to	our	hospital	due	 to	
pelvic	 mass	 diagnosed	 at	 the	 ultrasound	 examination.	 History	
revealed	 hospitalization	 due	 to	 multiple	 peritoneal	 tumors	 4	
months	 prior	 to	 admission.	 Biphasic	 computer	 tomography	
examination	 showed	 polycyclic	 mass	 measuring	 110x62mm	
with	 the	 intestine	 as	 a	 probable	 point	 of	 origin.	 Behind	 the	
uterus	 there	was	 also	 a	 cyst,	measuring	 54x45mm.	No	 ascites	
nor	 enlarged	 lymph	 nodes	 were	 observed.	 Other	 abdominal	
cavity	 organs	 i.e.	 liver,	 kidneys,	 adrenals,	 pancreas	 or	 spleen	
were	 normal.	 Subsequent	 pan-colonoscopy	 did	 not	 reveal	 any	
abnormalities.	Serum	biochemical	tumor	markers	were	negative	
(SCC-squamous	cell	carcinoma	antigen,	CA	19-9	(carbohydrate	
antigen	19-9),	CYFRA	21.1,	CEA	(carcinoembryonic	antigen),	
CA-125	(Cancer	Antigen-125),	CA-15,3	(Cancer	Antigen-15,3).	
Serum	levels	of	alpha-fetoprotein	(AFP)	were	slightly	above	the	
normal	range	(10.1	IU/ml).	
The	 patient	 was	 counseled	 and	 scheduled	 for	 surgical	
treatment.	 Laparotomy	 due	 to	 splenic	 flexure	 colon	 tumor	
suspicion	was	performed.	Multiple	abdominal	masses	were	found	
–	at	the	colon	mesenterium,	splenic	flexure	and	greater	omentum	
site.	Additionally,	one	mass	of	pelvic	location	was	noted.	None	of	
the	tumors	were	infiltrating	the	surrounding	tissues	or	organs.	All	
tumors	were	surgically	removed.	Histopathological	verification	
showed	epithelioid	atypical	neoplastic	cells	with	medium	mitotic	
activity.	
Additional	 immunohistochemical	 staining	 revealed	
HMB45	 (Human	Melanoma	 B-45)	 (+),	Melan	A	 (Melanocyte	
Antigen)	 (-),	 (Microphthalmia-associated	Transcription	Factor)	
MITF	 (+),	 SMA	 (Smooth	 Muscle	Actin)	 (+),	 CALDESMON	
(+),	 DESMINA	 (+).	 The	 diagnosis	 of	 PEC-oma	 tumor	 was	
established	on	the	basis	of	the	clinical	and	histological	findings.	
Postoperative	 period	 was	 uneventful	 and	 the	 patient	 was	
discharged	in	good	overall	condition.	On	day	59	after	surgery	she	
reported	at	 the	emergency	department	due	to	difficulty	passing	
urine.	 Ultrasound	 examination	 performed	 at	 that	 time	 did	 not	
show	 any	 abnormalities	 and	 the	 patient	was	 discharged	 home.	
Eighteen	days	after	that	episode	(77	days	since	the	surgery)	she	
had	 computer	 tomography	 performed	 privately.	 Tomography	
revealed	partially	 solid,	 partially	 cystic	pelvic	mass	measuring	
92x76mm.	Solid	 component	 of	 the	 tumor	 increased	 the	 signal	
density	after	 the	contrast.	The	tumor	displaced	the	bladder	and	
the	 rectum	with	 no	 signs	 of	 infiltration.	There	was	 no	 ascites,	
lymph	nodes	were	not	enlarged	and	abdominal	organs	appeared	
normal.	Gynecological	examination	showed	displacement	of	the	
cervix	and	palpable	solid	mass	occupying	the	pelvis.	Ultrasound	
examination	 revealed	 hyperechogenic	 mass	 within	 the	 uterus	
measuring	 as	 stated	 during	 tomography.	 Options	 of	 surgical	
treatment	 were	 discussed	 and	 total	 abdominal	 hysterectomy	
with	 bilateral	 salpingo-oophorectomy	 was	 scheduled.	 Second	
laparotomy	showed	massive	solid	adhesions	of	the	uterus,	adnexa	
and	 bowel	 loops.	 Uterus	 was	 of	 normal	 size	 with	 the	 tumor	
originating	from	the	posterior	wall	being	located	partially	within	
recto-vaginal	septum.	There	were	no	macroscopic	abnormalities	
within	ovaries.	The	procedure	was	uneventful	and	the	histological	
studies	of	the	provided	specimen	revealed	mesenchymal	tumor	
with	 necrotic	 foci.	 Additional	 immunohistological	 staining	
showed	positive	reaction	for	SMA	(+),	DESMINA	and	HMB45	
and	MIB1	(mitiotic	index,	prolferative	antigen	Ki67)	in	around	
10%	 of	 specimen	 cells.	 PEC-oma	was	 again	 confirmed	 in	 the	
final	diagnosis.
Discussion
The	 name	 perivascular	 epithelioid	 cells	 (PEC)	 was	
established	in	1992	by	Bonetti	et	al.,	who	described	morphemic	
and	immunohistochemical	characteristics	of	the	tumor	cells	[3].	
In	1996	Zamboni	et	al.,	proposed	the	name	for	the	whole	group	of	
tumors	including	already	mentioned	CCST,	CAM,	LAM	and	AML.	
The	WHO	definition	published	in	2002	states	that	PEComa	are	
mesenchymal	tumors	containing	perivascular	epithelioid	cells	of	
defined	morphology	and	immunohistochemistry.	Phenotypically,	
those	 tumors	 express	 on	 their	 surface	melanogenesis	 particles	
i.e.	 HMB-45,	 Melan-A	 (MART-1,	 melanoma	 associated	
antigen),	 centrally	 staining	 actin,	 desmin,	 vimentin	 and	do	not	
express	particles	of	epithelium	like	cytokeratin.	Unlike	cells	of	
clarocellular	sarcoma,	PEC-oma	does	not	express	S100	particles.	
Another	characteristic	is	abnormal	vascularization	of	the	tumor	
(LAM,	 AML)	 [5].	 Taking	 into	 account	 higher	 prevalence	 of	
PEC-oma	 in	women	 there	was	 a	 hypothesis	 linking	 the	 tumor	
with	hormonal	imbalance.	Some	studies	showed	the	presence	of	
the	progesterone	and	more	dominant	estrogen	 receptors	on	 the	
surface	of	the	PEC-oma	tumors	[6,7].	
Further	 studies	 showed	 that	 CD-1a	 particle	 present	 in	
the	 PEC-oma	 cells	 helps	 in	 differentiating	 the	 mass	 from	 the	
epithelioid	smooth	muscle	tumors	[8].	
In	 the	 literature	 there	 are	 studies	 showing	 coincidence	 of	
the	PEC-oma	and	tuberous	sclerosis	complex	(TSC),	autosomal	
dominant	 disease	 being	 characterized	 by	 epilepsy,	 mental	
retardation	 and	multiple	 tumors	 [6,9].	More	 recent	 studies	 did	
not	support	this	hypothesis.	
The	diagnosis	of	PEC-oma	is	 relatively	rare.	Second	most	
common	after	 the	uterus	 tumor	site	 is	gastrointestinal	 tract.	As	
far	as	the	last	localization	is	concerned,	the	differential	diagnosis	
involves	 melanoma,	 GIST	 (Gastrointestinal	 Stromal	 Tumors),	
clarocellular	tumors	of	soft	tissues,	sarcomas,	leyomyosarcomas	
and	 ganglioma.	 The	 malignancy	 potential,	 growing	 dynamics	
or	 patterns	 of	 PEC-oma	 tumors	 has	 not	 been	 clearly	 defined.	
Literature	data,	however,	supports	the	hypothesis	that	it	is	more	
prevalent	in	young	women	[10].	This	kind	of	tumor	can	be	located	
in	different	organs	with	the	uterus	being	the	most	frequent	one	[6,	
11].	One	study	showed	that	age	at	the	time	of	diagnosis	ranges	
from	17	to	79	years,	with	the	average	age	at	54	[12].	The	most	
common	 symptoms	were	 uterine	 bleeding,	 cramps	 or	 growing	
mass	in	the	hypogastric	area.	
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The	 prediction	 of	 the	 dynamics	 of	 the	 PEC-oma	 tumors	
appears	 difficult.	 Some	patients	 face	metastases,	 recurrence	 or	
fatal	course	of	the	disease	even	within	one	or	two	years	since	the	
surgical	 treatment	 [6,13].	Some	studies	suggested	sub-dividing	
the	group	into	three	subgroups	depending	on	the	prognosis	[1].	
The	so-called	benign	group	includes	masses	measuring	less	than	
5	cm	with	low	number	of	mitotic	divisions	(1<50HPF),	absence	
of	 multinuclear	 cells	 or	 cells	 with	 excessive	 cytoplasm.	 Two	
other	sub-groups	are	tumors	with	uncertain	and	high	malignancy	
potential,	 respectively,	 being	 characterized	 by	 multinuclear	
pleomorphic	cells.
In	most	cases	surgery	seems	to	be	the	treatment	of	choice.	
However,	 some	 patients	may	 benefit	 from	 the	 complementary	
therapy.	 Some	 studies	 described	 cases	 of	 metastatic	 PEC-
oma	with	 the	course	of	doxorubicin	and	 ifosphamide	 followed	
by	 radiotherapy	 [6]	 or	 only	 chemotherapy	 with	 ifosphamide	
following	surgical	procedure	[10].	One	study	presented	the	case	
of	a	9-year-old	patient	with	uterine	PEC-oma	with	lymph	nodes	
metastases	being	treated	by	surgery	followed	by	chemotherapy	
(ifosphamide,	vincristine,	and	doxorubicin)	and	radiotherapy	[1].	
Authors	of	the	study	claimed	remission	of	the	disease	with	the	
acute	lymphocytic	leukemia	diagnosed	4	years	after	aggressive	
treatment	 for	 PEC-oma	 [14].	One	 study	 presented	 the	 case	 of	
PEC-oma	 recurrence	 in	 lungs	 7	 years	 after	 primary	 surgical	
removal	of	the	uterine	mass	[15].	
In	conclusion,	present	data	is	insufficient	to	provide	reliable	
algorithms	for	PEC-oma	treatment	strategies.	The	presented	case	
and	literature	data	support	the	theory	that	even	though	surgical	
treatment	 appears	 to	 be	 primary	 and	 only	 choice,	 it	would	 be	
reasonable	 to	 consider	 complementary	 therapy	 and	 very	 close	
follow-up.
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